GST gene variants in synchronous colorectal cancers and synchronous association of colorectal cancers with other cancers

Chirurgia (Romania)

Volumn 108, Issue 3, 2013, Pages 365-371

  Chirila, D N ^a   Popp, R A ^a   Balacescu, O ^b   Turdeanu, N A ^a   Constantea, N A ^a   Pop, T R ^a   Vesa, S C ^a   Ciuce, C ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b Proteomics and Experimental Pathology Laboratory   (Romania)

Author keywords

Colorectal cancers; GSTM1; GSTP1; GSTT1; Other cancers; Synchronous lesions

Indexed keywords

EID: 84880796075     PISSN: 12219118     EISSN: 1842368X     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90.
2. Fante R, Roncucci L, Di Gregorio C, Tamassia MG, Losi L, Benatti P et al. Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients with hereditary colorectal carcinoma. Cancer 1996; 77(10):2013-21. (Pubitemid 26142043)
3. Langevin JM, Nivatvongs S. The true incidence of synchronous cancer of the large bowel. A prospective study. Am J Surg. 1984;147(3):330-3. (Pubitemid 14154580)
4. Eu KW, Seow-Choen F, Goh HS. Synchronous colorectal cancer in an oriental population. Int J Colorect Dis 1993;8(4): 193-196. (Pubitemid 24024878)
5. Piñol V, Andreu M, Castells A, Payá A, Bessa X, Jover R et al. Synchronous colorectal neoplasms in patients with colorectal cancer: predisposing individual and familial factors. Dis Colon Rectum 2004;47(7):1192-200. (Pubitemid 38857072)
6. Grodos J, Haot J. Synchronous cancers of the colon. Acta Endoscopica. 1987;17(1):11-17. (Pubitemid 17101976)
7. Evers BM, Mullins RJ, Matthews TH, Broghamer WL, Polk HC Jr. Multiple adenocarcinomas of the colon and rectum. An analysis of incidences and current trends. Dis Colon Rectum. 1988;31(7):518-22.
8. Koonin EV, Mushegian AR, Tatusov RL, Altschul SF, Bryant SH, Bork P, et al. Eukaryotic translation elongation factor 1 gamma contains a glutathione transferase domain-study of a diverse, ancient protein superfamily using motif search and structural modeling. Protein Sci. 1994;3(11):2045-54.
9. Dulhunty A, Gage P, Curtis S, Chelvanayagam G, Board P. The Glutathione Transferase Structural Family Includes a Nuclear Chloride Channel and a Ryanodine Receptor Calcium release Channel Modulator. J. Biol. Chem 2001; 276:3319-3323.
10. Harrop SJ, DeMaere MZ, Fairlie WD, Reztsova T, Valenzuela SM, Mazzanti M et al. Crystal structure of a soluble form of the intracellular chloride ion channel CLIC1 (NCC27) at 1.4- A resolution. J Biol Chem. 2001;276(48):44993- 5000.
11. Chirilã DN, Turdeanu NA, Constantea NA, Pop TR, Porumbel SD, Bungãrdean CI, et al. Synchronous cancers of the colon and rectum. HVM Bioflux. 2012;4(3):83-9.
12. Bajpai P, Tripathi AK, Agrawal D. Increased frequencies of glutathione-S-transferase (GSTM1 and GSTT1) null genotypes in Indian patients with chronic myeloid leukemia. Leuk Res. 2007;31(10):1359-63. Epub 2007 Apr 8. (Pubitemid 47212426)
13. Harries LW, Stubbins MJ, Forman D, Howard GC, Wolf CR. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis. 1997; 18(4):641-4. (Pubitemid 28132446)
14. Hohaus S, DiRuscio A, DiFebo A, Massini G, D'Alo' F, Guidi F et al. Glutathione S-transferase P1 genotype and prognosis in Hodgkin's lymphoma. Clin Cancer Res. 2005;11(6):2175-9. (Pubitemid 40490175)
15. Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116(3):544-73.
16. Siegel RL, Jemal A, Ward EM. Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev. 2009;18(6):1695-8.
17. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-917.
18. West N.J, Boustiere C, Fischbach W, Parente F, Leicester RJ. Colorectal cancer screening in Europe: differences in approach; similar barriers to overcome. Int J Colorectal Dis. 2009;24(7):731-40.
19. Palomaki GE, McClain MR, Melillo S, Hampel HL, Thibodeau SN. EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. Genet Med. 2009;11(1):42-65.
20. Meyer LA, Broaddus RR, Lu KH. Endometrial cancer and Lynch syndrome: clinical and pathologic considerations. Cancer Control. 2009;16(1):14-22.
21. Strafford JC. Genetic testing for lynch syndrome, an inherited cancer of the bowel, endometrium, and ovary. Rev Obstet Gynecol. 2012;5(1):42-9.
22. Cunliffe WJ, Hasleton PS, Tweedle DE, Schofield PF. Incidence of synchronous and metachronous colorectal carcinoma. Br J Surg. 1984;71(12):941-3. (Pubitemid 15218312)
23. Moertel CG, Bargen JA, Dockerty MB. Multiple carcinomas of the large intestine: a review of the literature and a study of 261 cases. Gastroenterology. 1958;34(1):85-98.
24. Ellis H. Prevention of recurrent cancer of the large bowel. Proc R Soc Med. 1974;67(9):857-8.
25. Adloff M, Arnaud JP, Bergamaschi R, Schloegel M. Synchronous carcinoma of the colon and rectum: prognostic and therapeutic implications. Am J Surg. 1989;157(3):299-302. (Pubitemid 19074558)
26. Gómez Iglesias S, Cuñat Albert E, Torregrosa Puerta S, Lozano Requena JA, Tovar Gómez O, Del Pino Porres J. Synchronous multiple carcinomas of the colon and rectum. Presentation of 18 cases and review of the literature. Rev Esp Enferm Apar Dig. 1989;76(4):316-20. Spanish.
27. Takeuchi H, Toda T, Nagasaki S, Kawano T, Minamisono Y, Maehara Y et al. Synchronous multiple colorectal adenocarcinomas. J Surg Oncol. 1997;64(4):304-7. (Pubitemid 27190820)
28. Norrie MW, Hawkins NJ, Todd AV, Meagher AP, O'Connor TW, Ward RL. The role of hMLH1 methylation in the development of synchronous sporadic colorectal carcinomas. Dis Colon Rectum. 2002;45(5):674-80. (Pubitemid 34507244)
29. Oya M, Takahashi S, Okuyama T, Yamaguchi M, Ueda Y. Synchronous Colorectal Carcinoma: Clinico-pathological Features and Prognosis. Jpn J Clin Oncol. 2003;33(1):38-43. (Pubitemid 43102879)
30. Nikoloudis N, Saliangas K, Economou A, Andreadis E, Siminou S, Manna I et al. Synchronous colorectal cancer. Tech Coloproctol. 2004;8(Suppl 1):s177-9. (Pubitemid 40394551)
31. Wang H, Zhang ZG, Song C, Wang B. Clinical research of synchronous colorectal neoplasms. Zhonghua Wai Ke Za Zhi 2006;44(21):1498-500.
32. Yalcinkaya U, Ozturk E, Ozgur T, Yerci O, Yilmazlar T. P53 expression in synchronous colorectal cancer. Saudi Med J. 2008;29(6):826-31.
33. Latournerie M, Jooste V, Cottet V, Lepage C, Faivre J, Bouvier AM. Epidemiology and prognosis of synchronous colorectal cancers. Br J Surg. 2008;95(12):1528-33.
34. Goldgraber MB, Kirsner JB. Carcinoma of the colon in ulcerative colitis. Cancer 1964;17:657-665.
35. Ritchie JK, Hawley PR, Lennard-Jones JE. Prognosis of carcinoma in ulcerative colitis. Gut 1981;22:752-755. (Pubitemid 12158882)
36. Greenstein AJ, Slater G, Heimann TM, Sachar DB, and Aufses AH Jr. A comparison of multiple synchronous colorectal cancer in ulcerative colitis, familial polyposis coli, and de novo cancer. Ann Surg. 1986;203(2):123-128. (Pubitemid 16144696)
37. Derwinger K, Gustavsson B. A study of aspects on gender and prognosis in synchronous colorectal cancer. Clin Med Insights Oncol. 2011;5:259-64.
38. Moertel CG. Multiple primary malignant neoplasms-their incidence and significance. Recent Results Cancer Res. 1966; 7:76-88.
39. Diamante M, Bacon HE. Primary multiple malignancy of the colon and rectum: report of 230 cases. Dis Colon Rectum 1966; 9:441-445.
40. Adelstein P, Baldwin JA, Fedrich J. Cancers of the large bowel: associated disorders in individuals. Cancer. 1979;43(6):2553-7. (Pubitemid 9252409)
41. Weir JA. Colorectal cancer: metachronous and other associated neoplasms. Dis Colon Rectum. 1975;18(1):4-5.
42. Kan JY, Hsieh JS, Pan YS, Wang WM, Chen FM, Jan CM et al. Clinical characteristics of patients with sporadic colorectal cancer and primary cancers of other organs. Kaohsiung J Med Sci 2006;22(11):547-53.
43. Meyer DJ, Coles B, Pemble SE, Gilmore KS, Fraser GM, Ketterer B. Theta, a new class of glutathione transferases purified from rat and man. Biochem J. 1991;274 ( Pt 2):409-14.
44. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J. 1994;300(Pt 1):271-6. (Pubitemid 24151046)
45. Tan KL, Webb GC, Baker RT, Board PG. Molecular cloning of a cDNA and chromosomal localization of a human theta-class glutathione S-transferase gene (GSTT2) to chromosome 22. Genomics 1995;25(2):381-7.
46. Tars K, Larsson AK, Shokeer A, Olin B, Mannervik B, Kleywegt GJ. Structural basis of the suppressed catalytic activity of wild-type human glutathione transferase T1-1 compared to its W234R mutant. J Mol Biol. 2006;355(1):96-105. (Pubitemid 41774142)
47. Moyer AM, Salavaggione OE, Hebbring SJ, Moon I, Hildebrandt MA, Eckloff BW et al. Glutathione S-transferase T1 and M1: gene sequence variation and functional genomics. Clin Cancer Res. 2007;13(23):7207-16. (Pubitemid 350276908)
48. Webb G. Vaska V, Coggan M, Board P. Chromosomal Localization of the Gene for the Human Theta Class Glutathione Transferase (GSTT1). Genomics 1996;33 (1):121-123. (Pubitemid 26119403)
49. Chenevix-Trench G, Young J, Coggan M, Board P. Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset. 1995;16(7):1655-7.
50. Board PG. Biochemical genetics of glutathione-S-transferase in man. Am J Hum Genet. 1981;33(1):36-43. (Pubitemid 11188461)
51. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev. 1997;6(9):733-43. (Pubitemid 27427630)
52. Yeh CC, Hsieh LL, Tang R, Chang-Chieh CR, Sung FC. Vegetable/fruit, smoking, glutathione S-transferase polymorphisms and risk for colorectal cancer in Taiwan. World J Gastroenterol. 2005;11(10):1473-80. (Pubitemid 40468082)
53. Sergentanis TN, Economopoulos KP. GSTT1 and GSTP1 polymorphisms and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 2010;121(1):195-202.
54. Wan H, Zhou Y, Yang P, Chen B, Jia G, Wu X. Genetic polymorphism of glutathione S-transferase T1 and the risk of colorectal cancer: a meta-analysis. Cancer Epidemiol 2010;34(1):66-72.
55. Yu L, Wang CY, Xi B, Sun L, Wang RQ, Yan YK, et al. GST polymorphisms are associated with hepatocellular carcinoma risk in Chinese population. World J Gastroenterol 2011;17 (27):3248-56.
56. Ates NA, Tamer L, Ates C, Ercan B, Elipek T, Ocal K et al. Glutathione S-transferase M1, T1, P1 genotypes and risk for development of colorectal cancer. Biochem Genet. 2005;43(3-4): 149-63. (Pubitemid 40543712)
57. Mannervik B, Danielson UH. Glutathione transferase structure and catalytic activity. CRC Crit Rev Biochem. 1988;23(3):283-337.
58. Sameer AS, Qadri Q, Siddiqi MA. GSTP1 I105V polymorphism and susceptibility to colorectal cancer in Kashmiri population. DNA Cell Biol. 2012;31(1):74-9.
59. Stoehlmacher J, Park DJ, Zhang W, Groshen S, Tsao-Wei DD, Yu MC et al. Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer. J Natl Cancer Inst. 2002;94(12):936-42. (Pubitemid 34778092)
60. Sweeney C, McClure GY, Fares MY, Stone A, Coles BF, Thompson PA et al. Association between survival after treat ment for breast cancer and glutathione S-transferase P1 Ile105Val polymorphism. Cancer Res. 2000;60(20):5621-4.
61. Shiga H, Heath EI, Rasmussen AA, Trock B, Johnston PG, Forastiere AA et al. Prognostic value of p53, glutathione Stransferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer. Clin Cancer Res. 1999;5(12):4097-104. (Pubitemid 30013791)
62. Chen HS, Sheen-Chen SM. Synchronous and "early" metachronous colorectal adenocarcinoma: analysis of prognosis and current trends. Dis Colon Rectum. 2000;43(8):1093-9.
63. Chirilã DN, Bungãrdean CI, Pop TR, Constantea NA. Total colectomy with J"-reservoir for synchronous neoplasia of the large bowel and rectum. HVM Bioflux 2012;4(2):68-75.
64. Economopoulos KP, Sergentanis TN. GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: a comprehensive meta-analysis. Eur J Cancer 2010;46(9):1617-31.